Oklahoma’s cannabis regulator has denied a business application to a company following a judge’s ruling that the business submitted fraudulent ownership information.
The case study follows a 61-year-old woman who was able to significantly reduce the dose of prescription medication she was taking to control her neuropathic pain after being prescribed a THC-containing cannabis oil.
State regulators in Colorado have issued two more health and safety notices after “potentially unsafe levels” of total yeast and mold and Aspergillus were found in certain pre-roll cigarettes and batches of cannabis flower.
To learn more about the services that are available to new cultivators setting up shop, Analytical Cannabis spoke with Arie Kamp, managing director at urban-gro Europe, a leading architectural and engineering firm that is already applying its design-build expertise to the cannabis industry.
Kenneth B. Walsh, a professor of pharmacology, physiology, and neuroscience at the University of South Carolina, updates us on the latest research from the world of synthetic cannabinoid receptor agonists.
Mark Lewis, president of Napro Research, outlines how genetics can be harnessed to secure the future of cannabis.
The findings could explain why the effects of psychedelics, such as neuroplasticity and even antidepressant action, vary between different drugs.
From July 1, psychiatrists in Australia will be allowed to prescribe MDMA and psilocybin as treatments for certain mental health conditions.